Gene-Environment Interactions Underlying the Effect of Cannabis in First Episode Psychosis

被引:0
作者
Maria Pelayo-Teran, Jose [1 ]
Suarez-Pinilla, Paula [1 ]
Chadi, Nicholas [3 ]
Crespo-Facorro, Benedicto [1 ,2 ]
机构
[1] Univ Cantabria, Dept Psychiat, IFIMAV, Hosp Univ Marques de Valdecilla,Sch Med, Santander 39008, Spain
[2] Ctr Invest Biomed Red Salud Mental, CIBERSAM, Madrid, Spain
[3] McGill Univ, Fac Med, Montreal, PQ H3G 1Y6, Canada
关键词
Schizophrenia; cannabinoids; gene-environment interaction; genetics; CB1; causality; COMT; CATECHOL-O-METHYLTRANSFERASE; SCHIZOPHRENIA-SPECTRUM DISORDERS; HETEROZYGOUS NEUREGULIN-1 MICE; BDNF VAL66MET POLYMORPHISM; NEUROLOGICAL SOFT SIGNS; CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; HIGH-RISK; DOPAMINE RELEASE; DEVELOPMENTAL EXPRESSION;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cannabis use may be considered as an additional risk factor in a diathesis-stress model of schizophrenia where the risk of developing the illness would be higher in genetic vulnerable people. In this regard, much of the research on cannabis and psychosis is currently focusing on gene-environment interactions. The present review will focus on the interaction between genes and cannabis exposure in the development of psychotic symptoms and schizophrenia and the biological mechanisms of cannabis. Cannabis use has been shown to act together with other environmental factors such as childhood trauma or urbanicity producing synergistic dopamine sensitization effects. Studies on gene-environment interaction have mainly included genetic variants involved in the regulation of the dopaminergic system. The most promising genetic variants in this field are COMT, CNR1, BDNF, AKT1 and NRG1. Additionally, the interaction with other environmental factors and possible gene-gene interactions are considered in the etiological model.
引用
收藏
页码:5024 / 5035
页数:12
相关论文
共 164 条
  • [91] Diagnosing schizophrenia in the initial prodromal phase
    Klosterkötter, J
    Hellmich, M
    Steinmeyer, EM
    Schultze-Lutter, F
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2001, 58 (02) : 158 - 164
  • [92] Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis
    Koethe, Dagmar
    Giuffrida, Andrea
    Schreiber, Daniela
    Hellmich, Martin
    Schultze-Lutter, Frauke
    Ruhrmann, Stefan
    Klosterkoetter, Joachim
    Piomelli, Daniele
    Leweke, F. Markus
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2009, 194 (04) : 371 - 372
  • [93] Replication in two independent population-based samples that childhood maltreatment and cannabis use synergistically impact on psychosis risk
    Konings, M.
    Stefanis, N.
    Kuepper, R.
    de Graaf, R.
    ten Have, M.
    van Os, J.
    Bakoula, C.
    Henquet, C.
    [J]. PSYCHOLOGICAL MEDICINE, 2012, 42 (01) : 149 - 159
  • [94] Rate of Cannabis Use Disorders in Clinical Samples of Patients With Schizophrenia: A Meta-analysis
    Koskinen, Johanna
    Lohonen, Johanna
    Koponen, Hannu
    Isohanni, Matti
    Miettunen, Jouko
    [J]. SCHIZOPHRENIA BULLETIN, 2010, 36 (06) : 1115 - 1130
  • [95] Schizophrenia and urbanicity: A major environmental influence - Conditional on genetic risk
    Krabbendam, L
    van Os, J
    [J]. SCHIZOPHRENIA BULLETIN, 2005, 31 (04) : 795 - 799
  • [96] Cannabis abuse and risk for psychosis in a prodromal sample
    Kristensen, Karin
    Cadenhead, Kristin S.
    [J]. PSYCHIATRY RESEARCH, 2007, 151 (1-2) : 151 - 154
  • [97] Do cannabis and urbanicity co-participate in causing psychosis? Evidence from a 10-year follow-up cohort study
    Kuepper, R.
    van Os, J.
    Lieb, R.
    Wittchen, H. -U.
    Henquet, C.
    [J]. PSYCHOLOGICAL MEDICINE, 2011, 41 (10) : 2121 - 2129
  • [98] Non-replication of interaction between cannabis use and trauma in predicting psychosis
    Kuepper, Rebecca
    Henquet, Cecile
    Lieb, Roselind
    Wittchen, Hans-Ulrich
    van Os, Jim
    [J]. SCHIZOPHRENIA RESEARCH, 2011, 131 (1-3) : 262 - 263
  • [99] Cognitive consequences of cannabis use: Comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions
    Lundqvist, T
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2005, 81 (02) : 319 - 330
  • [100] ENVIRONMENTAL-STRESS AS A FACTOR IN RESPONSE OF RAT-BRAIN CATECHOLAMINE METABOLISM TO DELTA-8-TETRAHYDROCANNABINOL
    MACLEAN, KI
    LITTLETON, JM
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1977, 41 (02) : 171 - 182